1718. In Vitro Activity of Imipenem/Relebactam against Class C β-lactamase-Positive Enterobacterales in the Asia/Pacific Region: SMART 2018-2020

BACKGROUND: Imipenem/relebactam (IMR) is a combination of imipenem/cilastatin with the β-lactamase inhibitor relebactam, an inhibitor of class A and C β-lactamases. We evaluated the activity of IMR and comparators against AmpC- and extended-spectrum β-lactamase (ESBL)-producing E. coli and K. pneumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Estabrook, Mark, Chen, Wei-Ting, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752709/
http://dx.doi.org/10.1093/ofid/ofac492.1348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752709/
http://dx.doi.org/10.1093/ofid/ofac492.1348

Ejemplares similares